Termedia Sp. z o.o.

At Termedia Sp. z o.o. in Poznan, clinical research in digestive system diseases focuses mainly on Crohn’s disease and ulcerative colitis. These studies are designed to assess new treatment options, improve long-term disease control, and better understand how to support patients with persistent inflammatory bowel conditions.

• Moderately to severely active Crohn’s disease and ulcerative colitis
• Testing therapies aimed at improving remission and symptom control
• Evaluating long-term safety, tolerability, and treatment effectiveness

The site is contributing to research on both established and emerging approaches for chronic gastrointestinal inflammation, with a strong emphasis on immune-mediated digestive disorders.

Research in immune system diseases at this clinical research site includes conditions such as primary Sjögren’s disease and inflammatory disorders that involve abnormal immune activity. The trials aim to evaluate whether new therapies can reduce disease activity and offer better control of chronic immune-related symptoms.

• Primary Sjögren’s disease with a focus on systemic disease activity
• Investigating treatment effectiveness in immune-mediated conditions
• Assessing safety and tolerability of novel therapies

These studies reflect an interest in improving care for patients whose illnesses affect multiple organs and require long-term management.

Clinical trials in skin and connective tissue diseases are centered on hidradenitis suppurativa and psoriatic arthritis. The research is aimed at finding better ways to control inflammation, ease chronic symptoms, and evaluate whether new therapies can provide lasting benefit for people living with these difficult-to-treat conditions.

• Hidradenitis suppurativa and its long-term treatment needs
• Psoriatic arthritis with attention to disease control and patient response
• Testing therapies for effectiveness, safety, and durability of benefit

This area highlights the site’s involvement in research on chronic inflammatory skin and joint diseases that can have a major impact on daily life.

In nervous system diseases, the site is studying agitation in patients with dementia of the Alzheimer’s type. The trial work is focused on evaluating whether a new treatment approach can help manage behavioral symptoms more effectively while maintaining acceptable safety and tolerability.

• Agitation linked to Alzheimer’s-type dementia
• Assessing symptom relief and overall treatment usefulness
• Supporting research on behavioral symptoms in neurodegenerative disease

These studies address an important area of neurology, where improving patient comfort and caregiver support is a key goal.

Trials in hormonal diseases at this site include research on vasomotor symptoms in women receiving hormone-related cancer treatment. The purpose is to test whether a new therapy can reduce hot flashes and related discomfort, helping improve quality of life during ongoing care.

• Moderate to severe vasomotor symptoms in women treated for hormone receptor-positive breast cancer
• Evaluating relief of hot flashes and symptom severity
• Studying supportive care options for treatment-related side effects

This work connects endocrine and oncology-related supportive care, with an emphasis on patient well-being.

Research in musculoskeletal diseases is represented by studies in psoriatic arthritis, a condition that affects the joints and is closely linked with immune-driven inflammation. The trials are intended to determine whether new therapies can improve symptoms, function, and long-term disease control.

• Psoriatic arthritis and inflammatory joint disease
• Testing treatment effectiveness for active disease
• Monitoring long-term safety and tolerability

At the Termedica specialist center, this area adds to a broader portfolio of research on chronic inflammatory conditions.